Ernexa Therapeutics Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2025-04-11: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-03-31; Total offering amount $7,249,999.
- 2024-11-14: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-09-24; Total offering amount $3,887,252.
- 2024-11-14: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-09-24; Total offering amount $1,137,746.
- 2023-12-20: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2023-12-15; Total offering amount $9,193,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2025-04-11 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2025-03-31 | $7,249,999 | $7,249,999 | $0 | 15 |
|---|
| 2024-11-14 | Rule 506(b) | Debt; OptionToAcquire; SecurityToBeAcquired | 2024-09-24 | $3,887,252 | $3,887,252 | $0 | 11 |
|---|
| 2024-11-14 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2024-09-24 | $1,137,746 | $1,137,746 | $0 | 5 |
|---|
| 2023-12-20 | Rule 506(b) | Equity; Debt; OptionToAcquire; SecurityToBeAcquired | 2023-12-15 | $9,193,000 | $7,788,000 | $1,405,000 | 19 |
|---|
| 2023-07-26 | Rule 506(b) | Equity; Debt; OptionToAcquire; SecurityToBeAcquired; 6% Senior Convertible Notes, shares of common stock, and common stock purchase warrants, including underlying common stock issuable upon conversion of Warrants and upon conversion of Notes. | 2023-07-14 | $8,715,000 | $8,715,000 | $0 | 19 |
|---|
| 2023-07-26 | Rule 506(b) | Equity; Debt; OptionToAcquire; SecurityToBeAcquired; 6% Senior Convertible Notes, shares of common stock, and common stock purchase warrants, including underlying common stock issuable upon conversion of Warrants and upon conversion of Notes. | 2023-07-14 | $8,715,000 | $8,715,000 | $0 | 19 |
|---|
| 2022-12-16 | Rule 506(b) | Equity; "Units consisting of (i) one share of common stock and (ii) two warrants to purchase one share common stock (""common warrants"")" | 2022-12-02 | $7,712,874 | $7,712,874 | $0 | 20 |
|---|
| 2022-03-23 | Rule 506(b) | Equity; "Units consisting of (i) one share of common stock and (ii) one warrant to purchase one share common stock (""common warrants"")" | 2022-03-09 | $12,000,000 | $12,000,000 | $0 | 1 |
|---|
| 2013-11-18 | Rule 506(b) | Equity; OptionToAcquire | 2013-11-12 | $3,840,000 | $2,400,000 | $1,440,000 | 6 |
|---|
| 2009-05-26 | Rule 506 | Equity; OptionToAcquire | 2009-05-11 | $2,250,000 | $2,250,000 | $0 | 0 |
|---|